| Name: | Montelukast Nitrile Impurity |
| Catalogue No. | VL510004 |
| CAS No. | 866923-62-8 |
| Molecular Formula | C₃₅H₃₅ClN₂OS |
| Molecular Weight | 567.18 |
| Status | In-stock |
| IUPAC Name | :1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetonitrile |
| Description | Montelukast Nitrile Impurity (CAS No: 866923-62-8) is an impurity present in the synthesis of montelukast which is used as an effective and well-tolerated oral treatment for allergic airway inflammation in patients with SAR or PAR without asthma. |
| References | “New and Practical Synthesis of Montelukast Sodium, an Antiasthmatic Drug.” Synthetic Communications, 2013, www.tandfonline.com/doi/abs/10.1080/00397911.2012.684755. Nayak, Anjuli, and Ronald B. Langdon. “Montelukast in the Treatment of Allergic Rhinitis.” Drugs, vol. 67, no. 6, 2007, pp. 887–901, https://doi.org/10.2165/00003495-200767060-00005. |
